Prosecution Insights
Last updated: April 19, 2026

Examiner: FOX, ALLISON M

Tech Center 1700 • Art Units: 1600 1633 1653 1759

This examiner grants 72% of resolved cases

Performance Statistics

71.6%
Allow Rate
+6.6% vs TC avg
681
Total Applications
+36.2%
Interview Lift
1280
Avg Prosecution Days
Based on 656 resolved cases, 2023–2026

Rejection Statute Breakdown

6.1%
§101 Eligibility
20.2%
§102 Novelty
28.5%
§103 Obviousness
25.2%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
17786517 METHODS AND COMPOSITIONS FOR CORRECTION OF DMD MUTATIONS Final Rejection President and Fellows of Harvard College
17681240 METHOD FOR INCREASING PROPORTION OF CD56 POSITIVE CELLS Final Rejection TERUMO KABUSHIKI KAISHA
17947360 WOUND HEALING AND TISSUE ENGINEERING Non-Final OA Children's Medical Center Corporation
17486855 ABCB5(+) STEM CELLS FOR TREATING OCULAR DISEASE Final Rejection Children's Medical Center Corporation
17863363 LPS Priming of Stromal Cells to Generate LPS-Specific Exosome Educated Macrophages Non-Final OA Wisconsin Alumni Research Foundation
17999583 FIBROBLAST THERAPY FOR PREVENTION AND REVERSION OF ANEURYSMS Non-Final OA FIGENE, LLC
18080134 HEMANGIO-COLONY FORMING CELLS Non-Final OA Astellas Institute for Regenerative Medicine
17639823 Methods for the Preservation of Reagent Red Blood Cells Using Carbon Monoxide Non-Final OA Hemanext Inc.
18298105 ANTIBODIES FOR MODULATING BINDING BETWEEN LRP AND WISE Non-Final OA STOWERS INSTITUTE FOR MEDICAL RESEARCH
17666325 SPERM PROCESSING METHOD, APPARATUS AND RELATED MEDIA COMPOSITIONS Non-Final OA Inguran, LLC
17284668 OXYGENATION MEDIA FOR EX-VIVO PRESERVATION OF ORGANS AND TISSUES Final Rejection VirTech Bio, Inc.
17980910 PLACENTAL TISSUE GRAFTS AND IMPROVED METHODS OF PREPARING AND USING THE SAME Non-Final OA MiMedx Group, Inc.
17654038 AMNIOTIC FLUID FORMULATION FOR TREATMENT OF JOINT PAIN OR DISORDERS Final Rejection MAM Holdings of West Florida, L.L.C.
17934263 Neo-Islets Comprising Stem and Islet Cells and Treatment of Diabetes Mellitus Therewith Final Rejection SymbioCellTech, LLC
17820391 USE OF PERFUSION DECELLULARIZED LIVER FOR ISLET CELL RECELLULARIZATION Non-Final OA Miromatrix Medical Inc.
17806626 NATIVE SOFT TISSUE MATRIX FOR THERAPEUTIC APPLICATIONS Non-Final OA CYTEX THERAPEUTICS, INC.
17755837 FIBROBLAST-BASED THERAPY FOR TREATMENT AND PREVENTION OF STROKE Non-Final OA SPINALCYTE LLC
17734795 THREE DIMENSIONAL HETEROGENEOUSLY DIFFERENTIATED TISSUE CULTURE Non-Final OA IMBA-Institut fur Molekulare Biotechnologie GMBH
17700283 DIAGNOSTIC AND THERAPEUTIC USES OF COMPOSITIONS COMPRISING PURIFIED, ENRICHED POTENT EXOSOMES CONTAINING DISEASE-BASED AND THERAPY BASED SIGNATURE CARGO Final Rejection SPIRITUS THERAPEUTICS, INC.
16780522 METHODS OF GENETICALLY MODIFYING ANIMAL CELLS Final Rejection Wilson Wolf Manufacturing, LLC

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month